I am a board-certified radiation oncologist with a wide range of clinical and research expertise, and I am a member of the multidisciplinary team that treats patients at Memorial Sloan Kettering’ facility in Rockville Centre, Long Island. This team-oriented approach allows my colleagues and me to deliver state-of-the-art care to patients who wish to be treated close to their homes.
I treat a wide variety of cancers, and I am particularly interested in using advanced radiation techniques to treat tumors located near critical organs, to both increase the therapeutic dose to the tumor and reduce the amount of radiation that reaches healthy tissues. Here at Memorial Sloan Kettering Rockville Centre, we offer advanced radiation therapy approaches that allow us to more precisely target radiation including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), 3D conformal radiation therapy, and high-dose-rate brachytherapy.
I have worked on a variety of clinical research projects, including studies evaluating techniques to minimize toxicities and late effects from radiation for head and neck cancers; studies using balloon brachytherapy to treat recurrent brain tumors; and studies of vaccine compliance rates in our patients. I am also interested in testing novel radiosensitizers that have the potential to enhance radiation therapies.
My training includes completion of a combined MD/PhD program, and I hope to bring cutting-edge therapies to my patients through translational research — the transfer of findings made in the laboratory directly to patients in the clinic.
- Clinical Expertise: Intensity-Modulated Radiation Therapy and High-Dose-Rate Brachytherapy for Head and Neck Cancers; Gastrointestinal Cancers; Breast Cancers; Lung Cancers; Gynecological Malignancies; Prostate Cancer; Brain Tumors; Lymphomas; and Soft Tissue Sarcomas.
- Languages Spoken: English
- Education: MD, PhD, University of Maryland
- Residencies: University of Pennsylvania Medical Center
Dutta PR, Sui BQ, Nataro JP. (2003) “Structure-Function Analysis of the Enteroaggregative E. coli Plasmid Encoded Toxin Using Scanning Linker Mutagenesis.” Journal of Biological Chemistry 2003 27(41):39912-20.
Herman JM, Petit, JH, Amin P, Kowk Y, Dutta PR, Chin LS. “Repeat Radiosurgery for Refractory or Recurrent Trigeminal Neuralgia: treatment outcomes and quality-of-life assessment.” International Journal of Radiation Oncology, Biology, and Physics, 2004 59(1):112-6.
Bar Ad V, Cheville A, Solin LJ, Dutta P, Both S, Harris EE. “Time Course of Mild Arm Lymphedema After Breast Conservation Treatment for Early-Stage Breast Cancer.” International Journal of Radiation Oncology, Biology, and Physics, 2010, 76(1): 85-90.
Bar Ad V, Weinstein G, Dutta PR, Chalian A, Both S, Quon H. (2010) “Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy.” Head and Neck. 32: 173-177.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more